BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 21, 2026; 32(23): 118240
Published online Jun 21, 2026. doi: 10.3748/wjg.v32.i23.118240
Table 1 Clinical characteristics of the study patients, mean ± SD/n (%)
Characteristic
Results (n = 75)
Age, years42.95 ± 19.90
SexMale27 (36.00)
Female48 (64.00)
BMI21.31 ± 3.34
History of blood transfusion28 (37.3)
NSAID1 (1.33)
Hypertension14 (18.67)
Diabetes3 (4.00)
Family history of hemangioma0 (0)
Hepatitis6 (8.0)
History of surgery and trauma35 (46.67)
History of radiotherapy and chemotherapy3 (4.00)
Abnormal coagulation16 (21.33)
Albumin, g/L39.09 ± 3.69
Hemoglobin, g/L86.03 ± 21.15
Interventional therapy62 (82.67)
Method of DBE insertionOral43 (63.24)
Anal25 (36.76)
Length of operation, minutes80.53 ± 27.83
Blood transfusion volume, mL225.00 ± 440.82
Active bleeding16 (21.33)
Lesion size, cm0.99 ± 0.61
Number of lesions3.62 ± 4.11
Location of lesionsDuodenum4 (5.33)
Upper jejunum18 (24.00)
Lower jejunum10 (13.33)
Upper ileum22 (29.33)
Lower ileum21 (28.00)
Treatment methodsConservative treatment13 (17.33)
Lauromacrogol injection20 (26.67)
Argon plasma coagulation therapy22 (29.33)
Ligation therapy18 (24.00)
Clip therapy2 (2.67)
Bleeding recurrence13 (17.33)


Write to the Help Desk